Sentinel lymph node biopsy is accurate and prognostic in head and neck melanoma

Abstract

BACKGROUND: Sentinel lymph node biopsy (SLNB) has emerged as a widely used staging procedure for cutaneous melanoma. However, debate remains around the accuracy and prognostic implications of SLNB for cutaneous melanoma arising in the head and neck, as previous reports have demonstrated inferior results to those in nonhead and neck regions. Through the largest single-institution series of head and neck melanoma patients, the authors set out to demonstrate that SLNB accuracy and prognostic value in the head and neck region are comparable to other sites. METHODS: A prospectively collected database was queried for cutaneous head and neck melanoma patients who underwent SLNB at the University of Michigan between 1997 and 2007. Primary endpoints included SLNB result, time to recurrence, site of recurrence, and date and cause of death. Multivariate models were constructed for analyses. RESULTS: Three hundred fifty-three patients were identified. A sentinel lymph node was identified in 352 of 353 patients (99.7%). Sixty-nine of the 353 (19.6%) patients had a positive SLNB. Seventeen of 68 patients (25%) undergoing completion lymphadenectomy after a positive SLNB result had at least 1 additional positive nonsentinel lymph node. Patients with local control and a negative SLNB failed regionally in 4.2% of cases. Multivariate analysis revealed positive SLNB status to be the most prognostic clinicopathologic predictor of poor outcome; hazard ratio was 4.23 for SLNB status and recurrence-free survival (P < .0001) and 3.33 for overall survival (P < .0001). CONCLUSIONS: SLNB is accurate and its results are of prognostic importance for head and neck melanoma patients. Cancer 2012;118:1040-

Advocating Sentinel Node Biopsy in the Management of Cutaneous Melanoma

“…In a recent large single-institutional series of primary melanomas with head and neck location [49], SNB demonstrated to be accurate and a prognostic tool in the management of these patients, challenging earlier reports that stated the opposite [50,51]. In our institution, we discuss and offer SNB to patients with melanomas ≥0.75 mm located in the head and neck region.…”

Ultrasmall Fluorescent Silica Nanoparticles as Intraoperative Imaging Tools for Cancer Diagnosis and Treatment

“…Erman [5] reported that in approximately 10 % of cases, there was a failure to identify any drainage pattern or to localize small nodes within the head and neck, an anatomically complex region. A major challenge in the intraoperative setting is the delineation difficult-to- b 124 I-cRGDY-PEG-ylated core-shell silica nanoparticle with surface-bearing radiolabels and peptides and corecontaining reactive dye molecules ( insets) detect nodes that are in anatomic proximity to tumor, precluding direct mapping of locoregional nodal distributions within an exposed nodal basin.…”

Sentinel lymph node biopsy for cutaneous head and neck malignancies

“…Three large single-institution reviews of SLNB for melanoma in the HN region show the technique is accurate, has low morbidity and has prognostic utility [36][37][38]. Despite bilateral drainage in 31% of patients, the sentinel node was identified in 96-98% of patients with a false omission rate comparable to other sites of the body of 1.4-4.5% 35.…”